course in Biological Technology

Physician to Implant the CATANIA(TM) Coronary Stent System With Polyzene(R)-F to Treat Chronic Total Occlusion During 'Live' Case at the Paris Cardiovascular Interventions Course (Francophone) 2008

Research Shows New Class of Stent Effective in Preventing Thrombosis, Restenosis, and Reocclusion PARIS, Oct. 1 /PRNewswire/ -- CeloNova BioSciences, Inc., today announced that Masahiko Ochiai MD, Associate Professor, Division of Cardiology, Yokohama Hospital, Kanagawa, J...

BioMS Medical announces its intention to renew a normal course issuer bid

Toronto Stock Exchange Symbol: MS EDMONTON, Sept. 3 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS) a leading developer in the treatment of multiple sclerosis (MS), announced today that it is renewing its normal course issuer bid. Under the bid, which will be conducted pursuant to the ...

BioMS Medical announces its intention to renew a normal course issuer bid

Toronto Stock Exchange Symbol: MS EDMONTON, Aug. 20 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS) a leading developer in the treatment of multiple sclerosis (MS), announced today that it is renewing its normal course issuer bid. Under the bid, which will be conducted...

LPGA Pro, Jill McGill, Encourages Indoor and Outdoor Allergy Sufferers to Challenge Their Course

ATLANTA and BRIDGEWATER, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Ladies Professional Golf Association (LPGA) player Jill McGill and the Asthma and Allergy Foundation of America (AAFA) have teamed up with UCB and sanofi-aventis to launch the Challenge Your Course campaign. The campaign is desig...

University of Wisconsin enriches course web sites with streaming media

When putting class notes and PowerPoint slides online is not enough, faculty and staff at the University of Wisconsin can use streaming video and audio to liven up their course Web pages thanks to a program funded jointly by the university and an AT&T grant. The services web site, Streaming Med...

Entrepreneurs get crash course for building a successful company

The second annual Wisconsin Entrepreneurs Conference got off to a dynamic start on Tuesday morning at the Hyatt Regency Milwaukee, treating at least a hundred entrepreneurs and industry representatives to a crash course in making a new company a success. The entrepreneurial boot camp was designed ...

UW professors get grants to engage technology for course delivery

Madison, Wis. -- UW-Madison Civil and Environmental Engineering professor Steve Cramer and Engineering Physics professor Jake Blanchard have both received approximately $40,000 from the John and Jean Berndt Technology-Enhanced Learning Initiative to develop innovative teaching approaches. Cra...

Above par: Playing 18 holes on Wisconsin's high-tech course

MADISONIt's PGA Championship Week in Wisconsin, which means the golfing world will beat a path to one of the state's most spectacular doorsteps, the 7,514-yard Whistling Straits course in Kohler. With lake-hugging holes named Grand Strand, Cliff Hanger and Voyageur, it's an inspiring place for th...

New WARF investment director plans to keep steady course

Madison, Wis. The Wisconsin Alumni Research Foundation has hired a new director of investment, who has worked with the organization since December 1 and was officially announced Wednesday. WARF licenses the patents generated by University of Wisconsin-Madison researchers to companies in Mad...

The Law Offices of Brian D. Witzer Wins 6+ Million Dollar Verdict

... for an adverse reaction were needed before prescribing Allopurinol to my client." stated Brian D. Witzer, principal of the law firm. "Had the correct course of action been taken, my client would not have had to suffer this horrible, disfiguring disease." Prior to trial, the Plaintiff settled with two othe...

China Sky One Medical, Inc. Appoints New Independent Director

...e from North Illinois University in 1989 and a Ph.D. in Political Science from Massachusetts Institute of Technology in 1994, where he completed MBA course work at Sloan School. He completed post-doctoral studies at the Fairbank Center for East Asia Studies, Harvard University , in 1995. "We are v...

The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.

...ion of three drugs - docetaxel (Taxotere(R)), oxaliplatin injection (Eloxatin(R)) and enoxaparin sodium injection (Lovenox(R)) - will be made over the course of one year. "At a time when the costs of managing clinical trials are on the rise and budgets are extremely tight, receiving pharmaceutical ...

DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD

...nt was successfully measured as a secondary endpoint (p-value = 0.005) in the previous Phase 3 study as a key measure of durability following a 50-day course of treatment with orBec(R) (i.e., 30 days following cessation of treatment). About DOR BioPharma, Inc. DOR BioPharma, Inc. (DOR) is a late-...

Global Jatropha Hi-Tech Agricultural Training Programme (JWTP)

... feedstocks emerged over the past year as apart from Jatropha, the training course also includes two other important new non-food biodiesel crops. ... feedstocks emerged over the past year as apart from Jatropha, the training course also includes two other important new non-food biodiesel crops. CJP ...

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

...lioidosis. In June, the company announced that Restanza demonstrated a 100% survival rate against an inhaled lethal dose of anthrax following a 14-day course of treatment in a second non-human primate study. The study was supported by the National Institute of Allergy and Infectious Diseases (NIAID). ...

Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications

...nd of September," stated Christopher J. Reinhard, Chairman and Chief Executive Officer of Cardium Therapeutics and Tissue Repair Company. "During the course of this landmark gene therapy trial, we have observed some remarkable healing responses as reported in the media by our medical centers from around th...

RadMD First to Offer CME-Certified Education and Training For Medical Imaging in Clinical Trials

...dical images." Founded by medical imaging experts Kohkan Shamsi, MD, PhD, and Richard Patt, MD, RadMD will offer both CME-certified and non-CME course modules providing clinical trial personnel with formalized training and testing on a variety of topics related to the use of medical imaging in clinic...

Zimmer Launches New Medical Education and BioSkills Training Program

..., hands-on cadaver-based training and surgeon-to-surgeon training programs. course modules have been tailored to match an individual surgeon's experience leve...o providing medical and dental professionals with unparalleled training and course offerings that will not only teach them how to use our products safely and ...

Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payer Access & Insights

... ABOUT BEST PRACTICES, LLC Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Prac...

Gerresheimer Holds its own in Difficult Environment

...ted EBITDA margin of 18.0% to 18.5%. In the course of its continued focus on the markets of pharma &a...n the first half year. Fore­casts for the further course of the financial year are difficult. Gerresheimer ...he fact that the divestment was carried out in the course of the financial year and is therefore included in...

Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease

... without AD. These analyses were comprised of an evaluation of claims data for more than 33 million Americans from a managed care population over the course of eight years. The study authors concluded that the most notable serious conditions were decubitus ulcers (bed sores, 5-fold higher), seizures (4-fo...

Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease

...d States and Europe. Numerous clinical studies have demonstrated that modest improvements in ADAS-cog scores - on the order of 2 to 3 points over the course of a year - have been associated with significant cost reductions in overall managed care expenditures. To further investigate pharmacogeno...

GPhA Calls Senate HELP Committee Action Disappointing for Countless Patients

...e already has the FDA working on creating a pathway and it has firmly stated that seven years of exclusivity is a good compromise. We must follow the course of the White House and Chairman Waxman and ensure that patients can truly access lifesaving biogeneric medicines in a timely manner. "We h...

Information warfare in the 21st century: Ideas are sometimes stronger than bombs

... field, the guiding principal being that just like in conventional warfare, the country must initiate and not be dragged behind the other side, and of course it must rely on intelligence. "There is a major difference between gathering intelligence for military fighting and gathering intelligence for informa...

Novel method predicts impact of a covert anthrax release

...ith Legrand, lead author of the study from the MRC Centre for Outbreak Analysis and Modelling, said: "We have devised a new way to forecast the future course of a potential outbreak and the people and geographic areas likely to be worst affected." Anthrax has the potential to cause a large number of dea...

Johnson & Johnson Completes Acquisition of Cougar Biotechnology

...ech Oncology Research & Development. "Abiraterone acetate now becomes one of many new treatments we are developing, which we hope will change the course of cancer treatment by targeting cancer cells and the tumor microenvironment." About Johnson & Johnson Caring for the world, one person ...

REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients

...appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases. Consideration should be given to changing the therapeutic regimen, ...

CEL-SCI Corporation Releases Letter to Shareholders

...al need. FDA granted Multikine Orphan Drug status in the USA. Our clinical success would be huge since Multikine would be on course to become the recommended first-line treatment for head and neck cancer. From there, we could hopefully prove that Multikine is likely to work agains...

How much is life worth? The $440 billion question

... powered to detect a survival advantage of two months or less should test only interventions that can be marketed at a cost of less than $20,000 for a course of treatment. Every life is of infinite value, the authors say, but spiraling costs of cancer care makes this dilemma inescapable. "The current ...

Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment

...h test designed to evaluate an adult's ability to attend, initiate, and complete written seatwork. The PERMP was administered at intervals during the course of the simulated workplace environment day. "This study provides important information for physicians about the effect of treatment with VYVANSE ...

Qforma Appoints Four Executives in Sales and Field Operations

...stomers, as represented by these four experienced and extremely talented individuals." Mark J. Grove has held multiple sales positions over the course of his career in the healthcare industry, with a proven record of exceeding goals and advancing to positions of increasing responsibility at such comp...

World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

... San Jose, CA (PRWEB) June 25, 2009 -- Nanomedicine represents a principal domain of nanotechnology that offers capability to significantly change the course of treatment of life-threatening diseases. Unlike other therapies, nanomedicine enhances efficacy and significantly minimizes adversities associated w...

Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study

...nce-a-day, oral antibiotic Restanza(TM) (cethromycin), showed that a 14-day course of Restanza achieved a 100% survival rate against an inhaled lethal dose of...ins of anthrax. In May 2007, a non-human primate study showed that a 30-day course of oral Restanza was 100% protective against a lethal dose of inhaled anthr...

Pharmaceutical Institute Launches New E-Course Focused on Health Policy

...ing solutions for the pharmaceutical and biotech industry, today announced the release of a new e-course titled, Introduction to Health Policy . The course is the newest addition to the company's Managed Markets Excellence(TM) series. The new Introduction to Health Policy e-course provides a comprehe...

Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia

... two prior treatments with chemotherapy (2nd salvage treatment). A dose of 2000 mg/m2/day was given as continuous infusion for five days. One repeated course was allowed in order to attain remission. Elacytarabine showed a favourable safety profile and clinical responses have been reported throughout the ph...

Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once-Daily INFERGEN(R) with Ribavirin in Hepatitis C Virus Treatment Failures

...rrish, President and CEO of Three Rivers Pharmaceuticals. Approximately 50% of patients with chronic hepatitis C fail to respond to their initial course of PEG-IFN/RBV therapy. No standard has yet emerged for second-line therapy, since simply repeating the same treatment, in well controlled trials, ha...

Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update

...fect the Company's planned IND filings and clinical trials, and the risk of obtaining negative findings or factors that may become apparent during the course of research or development which may result in the discontinuation or delay of the research or development projects; the risk of technical obsolescenc...

Finesse Solutions Expands Into State-of-the-Art Facility in San Jose, CA, USA

...en allocated for a future cell culture growth facility, in order to allow Finesse to further optimize and expand its product offering. "Over the course of the last year, Finesse has expanded its business more rapidly than expected. We are pleased to announce that our new facility provides the capacit...

Guy J. Quigley Resigns as Chairman and CEO of The Quigley Corporation: Quigley Leaves Company He Founded 20 Years Ago

... stockholders Guy J. Quigley, Chairman, President and Chief Executive Officer stated, "Despite everything that has been said and done during the course of this proxy contest, my goal has been and continues to build stockholder value. I am very proud of our work over the past 20 years. COLD-EEZE is a...

AEterna Zentaris Discloses Preliminary Phase 2 Trial Results for Perifosine in Combination with Radiotherapy for Non-Small Cell Lung Cancer

... Starting one week before the onset of a 4-week course of radiotherapy (51 Gy in 17 fractions), patients ...perable NSCLC, mainly Stage III, received a 5-week course of 150 mg perifosine daily or placebo. After end o...up despite the short duration of treatment (5-week course of 150 mg perifosine daily). There were no safet...